- AU$19.15m
- -AU$14.02m
- AU$0.23m
Australia Stock Exchange release from OPTHEA : PRE_NR Ends: 17:13:11
Australia Stock Exchange release from OPTHEA : S&P DJI Announces March 2022 Quarterly Rebalance
Australia Stock Exchange release from OPTHEA : Opthea appoints Dr.Joel Naor M.D as Chief Medical Officer
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : PRE_NR Ends: 08:49:41
Australia Stock Exchange release from OPTHEA : Opthea Half Year Report and Accounts
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Becoming a substantial holder
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : PRE_NR Ends: 09:06:55
Australia Stock Exchange release from OPTHEA : Angiogenesis 2022 -Prof Cheung presentation of PCV data
Australia Stock Exchange release from OPTHEA : Opthea data for OPT-302 in patients with PVC as presented
Australia Stock Exchange release from OPTHEA : PRE_NR Ends: 08:36:10
Australia Stock Exchange release from OPTHEA : Opthea present at SVB Leerink Global Healthcare Conference
Australia Stock Exchange release from OPTHEA : Opthea presents at the Angiogenesis 2022 Conference
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding
Australia Stock Exchange release from OPTHEA : Change in substantial holding